Close
Novotech
Jabsco PureFlo 21 Single Use

Press Releases

Turkish Cargo expands the Pharma Corridor in its wide flight network

Turkish Cargo, the fastest growing global air cargo brand thanks to its wide flight network, keeps bringing health to the world by carrying pharmaceuticals between destinations certified by the global aviation authorities. The successful brand has created a pharma corridor...

Anixa Biosciences collaborates with Urology Centers of Alabama on Cchek early prostate cancer detection study

Anixa Biosciences, Inc., a biotechnology company, announced a collaboration with Urology Centers of Alabama (UCA) in the Cchek early prostate cancer detection study. UCA will provide patient samples in Anixa's ongoing study, including support of clinical validation of Anixa's...

Biogen completes enrollment in phase 3 STAR study of gene therapy timrepigene emparvovec to treat inherited retinal disorder

Biogen Inc, a global biotechnology company, announced the enrollment of the last patient in the global phase 3 STAR clinical study, which is evaluating the investigational gene therapy timrepigene emparvovec (BIIB111/AAV2-REP1) for the treatment of choroideremia (CHM). CHM is...

Aptar Pharmas Preservative-Free Multidose Dispenser Approved in the US for Allergans REFRESH RELIEVA PF Artificial Tear Formulation

Aptar Pharma, a leading drug delivery systems provider, is pleased to announce that its innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the delivery system for Allergan’s REFRESH® RELIEVA™ PF, its new over-the-counter (OTC) preservative-free treatment for eye dryness in...

DuPont Reveals Enhanced Application and Innovation Center, Increased Production Capacity at CPhI India

DuPont Nutrition & Biosciences has consistently advanced its customers forward by ensuring global access to indispensable ingredients and unmatched expertise. At CPhI India, the company will showcase increased capacity on both fronts, in addition to several product innovations such...

WuXi STA Forms Strategic Partnership with Impact Therapeutics

STA Pharmaceutical Co Ltd – a subsidiary of WuXi AppTec – and Impact Therapeutics, a biotech focused on innovative drug discovery and development in anti-cancer therapeutics, announce the signing of a strategic partnership agreement. Under the terms of this...

CRISPR Therapeutics, Vertex Report First Data from Trials of Gene-Editing Treatment CTX001

CRISPR Therapeutics and Vertex Pharmaceuticals reported preliminary, mostly-positive safety and efficacy data from the first two patients enrolled in two Phase I/II trials assessing their CRISPR/Cas9 gene-edited therapy CTX001 for a pair of blood disorders—the first clinical trial of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »